InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: J-Belfort post# 39392

Sunday, 05/09/2021 7:02:12 PM

Sunday, May 09, 2021 7:02:12 PM

Post# of 44690
Very important that Aviptadil is the only possible finalist that is NOT a MAb. Just on that basis the EMA may include it, IMO.
Aviptadil will be less expensive and works.
"You Know."
Excellent DD by the Author, IMO.

https://www.reddit.com/r/ReliefTherapeutics/comments/n744kw/brparelief_therapeutics_is_almost_certainly_to_be/

BTW I noticed BRPA/NRX/RLF were the combined 'Headline'. NRLAAA...GLTA...